{Reference Type}: Journal Article
{Title}: AI-driven discovery of blood xenobiotic biomarkers in neovascular age-related macular degeneration using iterative random forests.
{Author}: Künzel SE;Frentzel DP;Flesch LTM;Knecht VA;Rübsam A;Dreher F;Schütte M;Dubrac A;Lange B;Yaspo ML;Lehrach H;Joussen AM;Zeitz O;
{Journal}: Graefes Arch Clin Exp Ophthalmol
{Volume}: 0
{Issue}: 0
{Year}: 2024 Jun 6
{Factor}: 3.535
{DOI}: 10.1007/s00417-024-06538-2
{Abstract}: <B>OBJECTIVE: </B>To investigate the xenobiotic profiles of patients with neovascular age-related macular degeneration (nAMD) undergoing anti-vascular endothelial growth factor (anti-VEGF) intravitreal therapy (IVT) to identify biomarkers indicative of clinical phenotypes through advanced AI methodologies.<BR><B>METHODS: </B>In this cross-sectional observational study, we analyzed 156 peripheral blood xenobiotic features in a cohort of 46 nAMD patients stratified by choroidal neovascularization (CNV) control under anti-VEGF IVT. We employed Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) for measurement and leveraged an AI-driven iterative Random Forests (iRF) approach for robust pattern recognition and feature selection, aligning molecular profiles with clinical phenotypes.<BR><B>RESULTS: </B>AI-augmented iRF models effectively refined the metabolite spectrum by discarding non-predictive elements. Perfluorooctanesulfonate (PFOS) and Ethyl β-glucopyranoside were identified as significant biomarkers through this process, associated with various clinically relevant phenotypes. Unlike single metabolite classes, drug metabolites were distinctly correlated with subretinal fluid presence.<BR><B>CONCLUSIONS: </B>This study underscores the enhanced capability of AI, particularly iRF, in dissecting complex metabolomic data to elucidate the xenobiotic landscape of nAMD and environmental impact on the disease. The preliminary biomarkers discovered offer promising directions for personalized treatment strategies, although further validation in broader cohorts is essential for clinical application.